MedPath

A clinical trial to study of Brihtyadi Ghan vati and laghu panchmoola kwath prakshalan and taila pichu in paripluta yonivyapad wsr PID

Phase 1
Conditions
Health Condition 1: N739- Female pelvic inflammatory disease, unspecified
Registration Number
CTRI/2023/08/056761
Lead Sponsor
State Ayurvedic college and hospital Lucknow UP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1• Patient willing for trial.

2• Married women

3• lower abdomen pain

4• Low back pain.

5• Abnormal cervical or vaginal discharge

6• Dyspareunia

Exclusion Criteria

1• Pregnant women

2• Unmarried

3• PID associated with prolapsed uterus.

4• Endometriosis/ Chocolate cyst.

5• Severe or chronic ill health condition like diabetes mellitus & Hypertension tuberculosis

etc.

6• Acute PID & peritonitis, tubo- Ovarian abscess, Genital tumor & malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To assess the efficacy of Brihatyadi Ghan vati and Laghu Panchmula kwath prakshalan <br/ ><br>with taila pichu in management of Paripluta Yonivyapad <br/ ><br> <br/ ><br>2)To assess the efficacy of trial therapy on <br/ ><br>subjective parameters like pain in lower abdomen low back pain vaginal discharge dyspareunia objective criteria like cervical motion tenderness fornix tendernessTimepoint: Final assessment will be done after completion <br/ ><br>of trial of 4 consecutive months (3 months with <br/ ><br>clinical therapy and 1 month drug free)
Secondary Outcome Measures
NameTimeMethod
To assess the efficacy of trial therapy on <br/ ><br>subjective parameters like pain in lower abdomen low back pain vaginal discharge dyspareunia objective criteria like cervical motion tenderness fornix tenderness USG finding ( fluid in pouch of Douglas)Timepoint: Follow up- Three follow up will be done at every 1month during the therapy
© Copyright 2025. All Rights Reserved by MedPath